Why MacroGenics (MGNX), Coherus BioSciences (CHRS) Should Be On Your Biotech Radar

Schwab Network

English - May 12, 2021 10:41 - 6 minutes - 28.5 MB - ★★★★★ - 23 ratings
News Commentary News Business News business news news commentary news Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: CarLotz CEO Covers Company Earnings

Next Episode: CFRA Lowers Consumer Discretionary Sector To Market Weight From Overweight

Brad Loncar discusses the broader outlook for the biotech sector, on what he calls one of the best days he has seen "in ages". Two of his stocks to watch within the sector are MacroGenics and Coherus BioSciences, and he talks through some of the opportunities that lay ahead in these two names.